Prior to the biologic era, the medical management of patients with inflammatory bowel disease (IBD) was dominated by the use of aminosalicylates, corticosteroids, and immunosuppressants.


Receptors Lysosphingolipid, Janus kinase inhibitors, Heterocyclic Compounds 3-Ring, Piperidines, Pyrimidines, Pyrroles, Inflammatory Bowel Disease, Triazoles, IBD, Indans, Drug Therapy, Oxadiazoles, therapeutic use, Anti-Inflammatory Agents Non-Steroidal, Adverse Effects, Phosphodiesterase Inhibitors, Mesalamine

Read More